Users self-report data and can connect wearables to the program, and Evidation provides a flu symptom survey when a change in their health is detected. The program can then direct patients to clinical studies and flu care in their areas, according to an Oct. 26 Evidation news release.
The program has enrolled 90,000 users so far.
“FluSmart helps individuals learn about meaningful changes in their activity data and get insights using Evidation’s battle-tested algorithms and information they share with us,” Evidation co-founder and co-CEO Christine Lemke said. “We have been studying and characterizing influenza-like illness using wearables since 2017, and FluSmart makes this expertise actionable for individuals. In addition to helping identify potentially symptomatic individuals, Evidation’s predictive models have proved effective for engaging diverse and historically underrepresented populations.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
